Skip to main content

Table 6 Results from Statistical Modelling (BB Model)

From: Comparing the mapping between EQ-5D-5L, EQ-5D-3L and the EORTC-QLQ-C30 in non-small cell lung cancer patients

 

EQ-5D-5L

EQ-5D-3L

 

Estimate

SE

P-value

Estimate

SE

P-value

Intercept

-1.51144

0.000060

<0.001

-0.0123

.003893

0.00248

Physical Functioning

0.02254*

0.004666

<0.001

0.08711

.002940

<0.001*

Role Functioning

0.009619*

0.004550

0.03867

0.00421

.002685

0.12215

Emotional Functioning

0.01904*

0.003192

<0.0001

0.00661

.002007

0.00166*

Cognitive Functioning

-0.00633

0.003312

0.06076

-0.00425

.002111

0.04858*

Social Functioning

-0.00013

0.002758

0.97120

-0.00035

.001973

0.85980

Global Health Status / QoL

0.001652

0.002772

0.55344

-0.00197

.001913

0.30724

Fatigue

0.003561

0.005282

0.50279

0.00443

.002979

0.14223

Nausea / Vomiting

0.000452

0.004514

0.92057

-0.00146

.002700

0.59069

Pain

-0.03479*

0.003512

<0.001

-0.01039

.001910

<0.001*

Dyspnoea

-0.00806*

0.002800

0.00553

0.00015

.001759

0.93233

Insomnia

0.002047

0.002388

0.39474

0.00193

.001491

0.20048

Appetite loss

0.005383*

0.002446

0.03161

0.0002

.001415

0.88807

Constipation

0.000454

0.002052

0.82565

0.0014

.001386

0.31650

Diarrhoea

0.000353

0.00274

0.20705

0.00393

.001841

0.03688*

Financial Problems

-0.004324

0.002182

0.07174

-0.00113

.001292

0.38527

  1. *Statistically significant at the two-sided 5 % level